Excellent quality and fast dispatch
Products arrived well-packaged with COA documentation included. Really appreciate the clear research-only labelling — exactly what I needed for my lab work.
James R.
Sydney, AU
hGH Fragment 177-191
AOD-9604 Australia
Everything researchers need to know about AOD-9604 — mechanism, published dosing protocols, side effect profiles, reconstitution, and how to source third-party tested AOD-9604 in Australia.
Quick facts
- Also known as: Fragment 177-191 (hGH Fragment)
- Form: Lyophilised powder (>99% purity)
- Variants: 5 mg
- 🇦🇺 3–5 business days
March 2025
Best local supplier I've found
Ordered three times now. HPLC verification results have been consistent each time. The pathway browsing structure makes it much easier to compare compounds.
Sarah K.
Melbourne, AU
Fast shipping, great documentation
Same-day dispatch on my last two orders. The batch COA was easy to locate and the product information pages are genuinely useful for research planning.
Michael T.
Brisbane, AU
Representative of verified researcher feedback.
Overview
What Is AOD-9604?
AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) with an additional tyrosine residue. It was specifically developed to research the fat-reducing effects of growth hormone without the growth-promoting or diabetogenic effects. It has been granted GRAS status by the FDA for use in food products.
Also known as Fragment 177-191 (hGH Fragment), AOD-9604 is supplied as a lyophilised research peptide for laboratory use only. Research indicates AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue models. Unlike full-length hGH, it does not affect IGF-1 levels or insulin sensitivity in preclinical studies. Its mechanism involves interaction with the beta-3 adrenergic receptor pathway.
Mechanism
How AOD-9604 Works — Research Mechanism
Research indicates AOD-9604 stimulates lipolysis and inhibits lipogenesis in adipose tissue models. Unlike full-length hGH, it does not affect IGF-1 levels or insulin sensitivity in preclinical studies. Its mechanism involves interaction with the beta-3 adrenergic receptor pathway.
- Modified fragment of human growth hormone (amino acids 177-191)
- Stimulates lipolysis without IGF-1 elevation
- Beta-3 adrenergic receptor pathway interaction
- No growth-promoting or diabetogenic effects of full-length hGH
- FDA GRAS status for food product research context
Research reference
AOD-9604 Dosage — Published Research Protocols
The following reference points are drawn from published research literature. These figures are provided for research reference only and do not constitute dosing recommendations. AOD-9604 is sold strictly for laboratory research use.
| Protocol tier | Published research detail |
|---|---|
| Research reference | Published literature varies by model and endpoint — consult primary sources for protocol-specific dosing in laboratory settings |
| Administration route | Subcutaneous injection is most common in published peptide research protocols |
| Frequency | Dosing frequency depends on compound half-life and research design — daily to weekly intervals reported in literature |
| Available vial sizes | 5 mg — select based on your laboratory protocol requirements |
| Titration | Many research protocols start at lower doses and escalate to assess receptor response and tolerability in models |
Research use only: FOR LABORATORY RESEARCH USE ONLY. Not for human consumption, injection, or therapeutic use. All products are sold strictly as research chemicals. By purchasing, you confirm you are 18+ and agree to use products solely for legitimate research purposes.
Safety research
AOD-9604 Side Effects — Research Findings
Side effect profiles documented in published AOD-9604 research depend on dose, route of administration, and model system. The following are commonly reported findings from research literature — not from personal use contexts.
- Minimal adverse events reported in published lipolysis research
- Does not affect IGF-1 or insulin sensitivity in preclinical studies
- Injection site reactions possible with subcutaneous administration
- Generally well-tolerated at research doses in literature
Handling
Reconstituting AOD-9604
AOD-9604 is supplied as a lyophilised powder and must be reconstituted before use in laboratory protocols. Use bacteriostatic water (0.9% benzyl alcohol) for multi-dose vials. Inject diluent slowly down the inside wall of the vial — do not shake vigorously.
Bacteriostatic water is available from EvoPeak. Store reconstituted peptide at 2–8°C and lyophilised powder at −20°C.
Shop bacteriostatic waterAustralia
How to Get AOD-9604 in Australia
Researchers in Australia can source AOD-9604 through EvoPeak — a local supplier offering third-party tested research compounds with batch-specific COA documentation and domestic shipping.
- 1
Browse AOD-9604 variants (5 mg) on the EvoPeak product page
- 2
Review the certificate of analysis (COA) for HPLC purity and mass spectrometry identity verification
- 3
Select your vial size and add to cart — prices include GST with same-day Australian dispatch
- 4
Receive your order with batch-specific quality documentation for laboratory traceability
Quality Standard
Research compounds need evidence, not guesswork.
Every shopping path leads back to the same core standard: research-use positioning, third-party quality signals, transparent documentation, and careful handling guidance.
HPLC/MS verified
Purity and identity checks support confident compound selection for controlled research.
Endotoxin screened
Quality review extends beyond purity so researchers can evaluate handling risk.
Batch documentation
COA-first product pages keep quality signals close to every purchase decision.
Australia shipped
Local fulfilment keeps delivery predictable for Australian research customers.
FAQ
AOD-9604 — Common Questions
What is AOD-9604?
Modified growth hormone fragment for lipolysis and fat metabolism research. AOD-9604 is a modified fragment of human growth hormone (amino acids 177-191) with an additional tyrosine residue. It was specifically developed to research the fat-reducing effects of growth hormone … It is supplied for laboratory research use only.
What is the AOD-9604 dosage used in research?
Published research uses varying doses depending on the model and endpoint. EvoPeak supplies 5 mg vials. All dosage information is for research reference only and does not constitute recommendations.
What are the side effects of AOD-9604?
Side effect profiles in published research depend on dose, route, and model system. Consult primary literature for compound-specific findings. All information is drawn from research contexts, not personal use.
Can I buy AOD-9604 in Australia?
Yes. EvoPeak supplies research-grade AOD-9604 to Australian researchers with HPLC/MS verification, batch-specific COA documentation, and domestic shipping. Products are for laboratory research use only.
How do I get AOD-9604 in Australia?
Order from the EvoPeak shop page, select your vial size, review the COA, and checkout with local Australian fulfilment.
How do I reconstitute AOD-9604?
AOD-9604 is supplied as lyophilised powder. Reconstitute with bacteriostatic water, inject diluent slowly down the vial wall without shaking, and store at 2–8°C once reconstituted. Bacteriostatic water is available from EvoPeak.
What purity standard does EvoPeak AOD-9604 meet?
Every batch undergoes HPLC purity analysis (targeting >99%), mass spectrometry identity verification, and endotoxin screening. Batch-specific COAs are available on the product page.
Is aod-9604 peptide the same as Fragment 177-191 (hGH Fragment)?
AOD-9604 is also known as Fragment 177-191 (hGH Fragment). Both refer to the same research compound supplied by EvoPeak.
Related compounds
Explore related research peptides
Ready to order AOD-9604?
Third-party HPLC/MS tested with batch-specific COA documentation. Shipped from Australia for laboratory research use only.